FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2886642793> ?p ?o ?g. }

• W2886642793 abstract "Adoptive cellular therapy (ACT) has resulted in durable anti-tumor responses for both solid and hematological malignancies, mediated by the persistence and activation of transferred T cells. Unfortunately most patients, especially those with solid tumors, continue to progress despite persistent T cells. Thus revealing challenges specific to the hostile microenvironment of solid tumors and a critical need to identify factors that limit ACT efficacy. Furthermore, serial patient biopsies are challenging to obtain and accessible peripheral blood does not reflect relevant cell interactions at the tumor site. Xenograft models that lack infiltrating human macrophages, NK cells and lymphocytes cannot faithfully recapitulate critical interactions within the tumor microenvironment. To overcome this limitation, we initiated ACT in the MISTRG mouse that supports hematopoiesis after transplantation of human CD34+ stem cells resulting in functional human innate and adaptive immune cells. Co-transplantation of the melanoma cell line (Me275) results in tumor infiltration by human macrophages (TAMs) supporting tumor progression. The cancer/testis antigen Melanoma associated Antigen Gene (MAGE)-A1 is an attractive ACT target due to broad expression in tumors and limited expression in normal tissues rendering off-tumor tissue toxicities unlikely. We have identified a high-affinity HLA-A*02:01-restricted TCR that recognizes MAGE-A1278-286 peptide (TCRMA1) and confers effector functions in transduced CD8 and CD4 T cells when co-transduced with CD8αβ. Ex vivo analysis of MISTRG T cell cytolysis and proliferation suggest that CD4+ T cell help is required in this model. After two weeks of in vitro expansion, CD4+ and CD8+ T cells from humanized MISTRG spleens were transduced and transferred into MISTRG littermates harboring MAGE-A1+ Me275. Although TCRMA1 treated mice subtly controlled the growth of Me275, the changes were not significant. However, compared to an irrelevant TCR, only TCRMA1 CD8+ T cells localized to tumor and persisted in blood and spleen 8 and 28 days post transfer. TCRMA1 CD8 T cells displayed an effector phenotype, with high levels of PD-1 expression characteristic of recently activated and/or exhausted T cells. These results suggest that TCRMA1 cells recognized the tumor and were consequently activated, but could not overcome suppression in the microenvironment, mirroring human studies. Additional studies are being initiated to overcome the specific factors associated with the TAMs that limit in vivo T cell function. This model provides an ideal environment to test next generation T cell therapies, such as addition of intrinsic co-stimulation, to enhance responses against solid tumors. Humanized MISTRG mice are a powerful tool to study suppression of ACT in vivo, offering streamlined approaches to overcome hostile tumor microenvironments before clinical translation.Citation Format: Megan S. McAfee, Trisha Sippel, Daniel Hunter, Jean Campbell, Thomas Schmitt, Robert Pierce, Anthony Rongvaux, Aude Chapuis. Humanized mouse model of MAGE-A1-targeted anti-melanoma T cell therapy [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 3569." @default.
• W2886642793 created "2018-08-22" @default.
• W2886642793 creator A5025395608 @default.
• W2886642793 creator A5035086451 @default.
• W2886642793 creator A5036934284 @default.
• W2886642793 creator A5042777290 @default.
• W2886642793 creator A5044945918 @default.
• W2886642793 creator A5053281028 @default.
• W2886642793 creator A5083390361 @default.
• W2886642793 creator A5087187593 @default.
• W2886642793 date "2018-07-01" @default.
• W2886642793 modified "2023-09-30" @default.
• W2886642793 title "Abstract 3569: Humanized mouse model of MAGE-A1-targeted anti-melanoma T cell therapy" @default.
• W2886642793 doi "https://doi.org/10.1158/1538-7445.am2018-3569" @default.
• W2886642793 hasPublicationYear "2018" @default.
• W2886642793 type Work @default.
• W2886642793 sameAs 2886642793 @default.
• W2886642793 citedByCount "0" @default.
• W2886642793 crossrefType "proceedings-article" @default.
• W2886642793 hasAuthorship W2886642793A5025395608 @default.
• W2886642793 hasAuthorship W2886642793A5035086451 @default.
• W2886642793 hasAuthorship W2886642793A5036934284 @default.
• W2886642793 hasAuthorship W2886642793A5042777290 @default.
• W2886642793 hasAuthorship W2886642793A5044945918 @default.
• W2886642793 hasAuthorship W2886642793A5053281028 @default.
• W2886642793 hasAuthorship W2886642793A5083390361 @default.
• W2886642793 hasAuthorship W2886642793A5087187593 @default.
• W2886642793 hasConcept C10882517 @default.
• W2886642793 hasConcept C126322002 @default.
• W2886642793 hasConcept C147483822 @default.
• W2886642793 hasConcept C154317977 @default.
• W2886642793 hasConcept C167672396 @default.
• W2886642793 hasConcept C202751555 @default.
• W2886642793 hasConcept C203014093 @default.
• W2886642793 hasConcept C2776090121 @default.
• W2886642793 hasConcept C2776107976 @default.
• W2886642793 hasConcept C2776156784 @default.
• W2886642793 hasConcept C2777658100 @default.
• W2886642793 hasConcept C2777701055 @default.
• W2886642793 hasConcept C28328180 @default.
• W2886642793 hasConcept C2911091166 @default.
• W2886642793 hasConcept C502942594 @default.
• W2886642793 hasConcept C55493867 @default.
• W2886642793 hasConcept C71924100 @default.
• W2886642793 hasConcept C86803240 @default.
• W2886642793 hasConcept C8891405 @default.
• W2886642793 hasConcept C95444343 @default.
• W2886642793 hasConceptScore W2886642793C10882517 @default.
• W2886642793 hasConceptScore W2886642793C126322002 @default.
• W2886642793 hasConceptScore W2886642793C147483822 @default.
• W2886642793 hasConceptScore W2886642793C154317977 @default.
• W2886642793 hasConceptScore W2886642793C167672396 @default.
• W2886642793 hasConceptScore W2886642793C202751555 @default.
• W2886642793 hasConceptScore W2886642793C203014093 @default.
• W2886642793 hasConceptScore W2886642793C2776090121 @default.
• W2886642793 hasConceptScore W2886642793C2776107976 @default.
• W2886642793 hasConceptScore W2886642793C2776156784 @default.
• W2886642793 hasConceptScore W2886642793C2777658100 @default.
• W2886642793 hasConceptScore W2886642793C2777701055 @default.
• W2886642793 hasConceptScore W2886642793C28328180 @default.
• W2886642793 hasConceptScore W2886642793C2911091166 @default.
• W2886642793 hasConceptScore W2886642793C502942594 @default.
• W2886642793 hasConceptScore W2886642793C55493867 @default.
• W2886642793 hasConceptScore W2886642793C71924100 @default.
• W2886642793 hasConceptScore W2886642793C86803240 @default.
• W2886642793 hasConceptScore W2886642793C8891405 @default.
• W2886642793 hasConceptScore W2886642793C95444343 @default.
• W2886642793 hasLocation W28866427931 @default.
• W2886642793 hasOpenAccess W2886642793 @default.
• W2886642793 hasPrimaryLocation W28866427931 @default.
• W2886642793 hasRelatedWork W2055715607 @default.
• W2886642793 hasRelatedWork W2904909612 @default.
• W2886642793 hasRelatedWork W2912621681 @default.
• W2886642793 hasRelatedWork W3039388108 @default.
• W2886642793 hasRelatedWork W3120170523 @default.
• W2886642793 hasRelatedWork W3158438576 @default.
• W2886642793 hasRelatedWork W4304979265 @default.
• W2886642793 hasRelatedWork W4312075079 @default.
• W2886642793 hasRelatedWork W4317383376 @default.
• W2886642793 hasRelatedWork W4327715451 @default.
• W2886642793 isParatext "false" @default.
• W2886642793 isRetracted "false" @default.
• W2886642793 magId "2886642793" @default.
• W2886642793 workType "article" @default.